Jones Hill Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Jones Hill Capital's VRTX Position: Q2 2026 in Review
Jones Hill Capital reduced its Vertex Pharmaceuticals (VRTX) stake by 90% in Q2 2026, selling an estimated $43.2M and leaving 11,123 shares worth $5.53M. The position accounts for 1.17% of the portfolio, ranked #25.
Jones Hill Capital first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. The position peaked at $48.5M in Q1 2026. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Jones Hill Capital held 11,123 shares of Vertex Pharmaceuticals worth $5.53M as of Q2 2026.
- Jones Hill Capital sold 97,480 Vertex Pharmaceuticals shares in Q2 2026, an estimated $43.2M.
- Vertex Pharmaceuticals made up 1.17% of Jones Hill Capital's portfolio in Q2 2026, its #25 holding.
- Jones Hill Capital first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- Jones Hill Capital's Vertex Pharmaceuticals position peaked at $48.5M in Q1 2026.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Jones Hill Capital's 13F filing for Q2 2026, filed 13 Aug 2026.